Clinical Trial Update: Evaluating Efficacy and Safety of Oral Melatonin in Acute Central Serous Chorioretinopathy [Phase 2, Phase 3]

View source ↗

Summary

This document notes a Phase 2/3 clinical trial evaluating the efficacy and safety of orally administered melatonin for acute central serous chorioretinopathy, w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Serous Chorioretinopathy

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Mohsen Pourazizi | Conditions: Central Serous Chorioretinopathy, Melatonin | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING